Myricetin protects against doxorubicin-induced liver damage by modulating oxidative and inflammatory pathways
Abstract Background Doxorubicin (Dox) is a highly effective chemotherapy drug used to treat various cancers. However, its clinical application is limited by liver toxicity, which is mainly caused by oxidative stress, inflammation, and mitochondrial damage. Myricetin, a natural flavonoid present in m...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BMC
2026-01-01
|
| Σειρά: | BMC Pharmacology and Toxicology |
| Θέματα: | |
| Διαθέσιμο Online: | https://doi.org/10.1186/s40360-026-01088-1 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|